| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 1.17 |
—
|
| 2025 | 1.30 |
—
—
|
| 2024 | 0.88 |
—
|
| 2023 | 0.82 |
—
|
| 2022 | 0.53 |
—
|
| 2021 | 0.60 |
—
|
| 2020 | 0.57 |
—
|
| 2019 | 2.01 |
—
—
|
| 2018 | 3.30 |
—
—
|
| 2017 | 4.08 |
—
—
|
| 2016 | 4.00 |
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 10,904.00 | 11,949.00 | 12,527.00 | 8,640.00 |
| Receivables | 6,846.00 | 5,997.00 | 6,946.00 | 8,026.00 |
| Inventory | 5,583.00 | 5,020.00 | 5,107.00 | 5,528.00 |
| Other | — | — | — | — |
| 23,367.00 | 22,999.00 | 24,769.00 | 22,242.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 25,981.00 | 23,804.00 | 25,455.00 | 24,605.00 |
| ST’ Debt | 3,987.00 | 1,449.00 | 885.00 | 3,381.00 |
| Other | 5,587.00 | 6,008.00 | 6,296.00 | 4,226.00 |
| 37,156.00 | 33,066.00 | 34,475.00 | 33,476.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 15,267.00 | 16,660.00 | — | — |
—
|
| ’25 | 13,628.00 | 15,004.00 | 15,133.00 | 15,555.00 |
59,320.00
|
| ’24 | 14,547.00 | 15,333.00 | 15,046.00 | 14,842.00 |
59,768.00
|
| ’23 | 14,213.00 | 15,120.00 | 15,574.00 | 14,473.00 |
59,380.00
|
| ’22 | 13,235.00 | 14,793.00 | 15,091.00 | 14,667.00 |
57,786.00
|
| ’21 | 12,293.00 | 13,539.00 | 14,274.00 | 14,198.00 |
54,304.00
|
| ’20 | 11,003.00 | 10,294.00 | 12,816.00 | 12,768.00 |
46,881.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | 5,241.00 | — | — |
—
|
| ’25 | — | 2,704.00 | — | 2,704.00 |
14,883.00
|
| ’24 | — | 2,568.00 | — | 15,055.00 |
15,055.00
|
| ’23 | — | 1,597.00 | — | 13,265.00 |
13,265.00
|
| ’22 | — | 2,182.00 | — | 13,298.00 |
13,298.00
|
| ’21 | — | 3,939.00 | — | 14,799.00 |
14,799.00
|
| ’20 | — | 1,119.00 | — | 10,891.00 |
10,891.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | 3,881.00 | — | — |
—
|
| ’25 | — | 1,355.00 | — | 1,355.00 |
11,331.00
|
| ’24 | — | 885.00 | — | 11,320.00 |
11,320.00
|
| ’23 | — | (466.00) | — | 8,783.00 |
8,783.00
|
| ’22 | — | 243.00 | — | 8,460.00 |
8,460.00
|
| ’21 | — | 1,835.00 | — | 9,301.00 |
9,301.00
|
| ’20 | — | (405.00) | — | 7,204.00 |
7,204.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.30 | 1.90 | — | — |
—
|
| ’25 | 1.08 | 0.84 | 0.53 | 0.99 |
3.45
|
| ’24 | 0.54 | 0.73 | 1.03 | 0.61 |
2.92
|
| ’23 | 0.81 | 0.17 | 0.73 | 0.94 |
2.65
|
| ’22 | 0.05 | 0.79 | 0.71 | 1.41 |
2.97
|
| ’21 | 0.30 | 0.93 | 0.12 | 0.98 |
2.33
|
| ’20 | (1.13) | 0.18 | 0.52 | 1.13 |
0.70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.51 | 51.66 | 49.66 | 45.94 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 67.91 | 67.09 | 67.49 | 72.13 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 166,632 | 155,000 | 143,885 | 136,805 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.35 | 0.38 | 0.42 | 0.43 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 57,786.00 | 59,380.00 | 59,768.00 | 59,320.00 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54.48% | 53.86% | 55.25% | 55.93% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,524.00 | 9,124.00 | 10,568.00 | 11,328.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.48% | 15.37% | 17.68% | 19.10% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,597.00 | 6,891.00 | 7,416.00 | 8,477.00 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,078.00 | 5,411.00 | 5,544.00 | 5,652.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.71 | 29.45 | 29.84 | 29.90 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 2.97 | 2.65 | 2.92 | 3.45 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.61 | 6.58 | 7.52 | 7.50 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.40) | (2.22) | (1.86) | (1.79) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.20 | 4.36 | 5.65 | 5.71 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.87 | 45.97 | 44.28 | 49.26 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,013.00 | 2,016.00 | 2,003.00 | 1,984.00 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.14 | 24.25 | 17.21 | 18.62 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.08 | 2.18 | 1.68 | 2.14 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.42 | 1.40 | 1.13 | 1.30 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.28 | 3.31 | 2.69 | 3.16 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.55 | 11.56 | 7.82 | 12.57 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,298.00 | 13,265.00 | 15,055.00 | 14,883.00 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4,838.00) | (4,482.00) | (3,735.00) | (3,552.00) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,460.00 | 8,783.00 | 11,320.00 | 11,331.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (11,197.00) | (13,789.00) | (10,067.00) | (9,706.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 79,909.00 | 78,150.00 | 72,169.00 | 73,013.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 69,508.00 | 67,246.00 | 60,220.00 | 60,486.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 84,278.00 | 92,676.00 | 88,700.00 | 97,736.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.77% | 2.47% | 2.75% | 3.21% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.90% | 5.46% | 6.50% | 6.09% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.30% | 6.04% | 6.46% | 7.33% | — | — | — |
ROE
|
Anheuser-Busch InBev (ABI) has demonstrated resilient revenue growth of 3.5% CAGR from $45.5 billion in 2016 to $59.8 billion in 2024, fueled by pricing power, premiumization, and expansion in emerging markets, even amid volume pressures and disruptions like COVID-19 and the 2023 Bud Light boycott. Operational efficiencies shine through a 30% headcount reduction to 144,000 employees, boosting revenue per employee by 89% to over $415,000, while aggressive deleveraging slashed total debt by 41% to $72.2 billion and net debt by 44%, driving free cash flow per share up 82% to $5.65 and supporting $21.6 billion in cumulative FCF generation.
Despite these strengths, gross margins contracted 11% to 55.3% due to input cost volatility and health-driven shifts to non-alcoholic variants, with EBT margins volatile but stabilizing at 17.7%. Trading at attractive multiples like 17x forward PE and 7.8x EV/FCF, ABI offers ~7% mean analyst upside, but lingering debt risks, U.S. volume declines, and geopolitical exposures temper enthusiasm—positioning it as a hold for patient income seekers betting on further deleveraging and margin recovery.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.